Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran 
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm 
Instagram Outage Disrupts Thousands of U.S. Users 
Thailand Inflation Remains Negative for 10th Straight Month in January 
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility 
The ghost of Robodebt – Federal Court rules billions of dollars in welfare debts must be recalculated 
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition 
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025 
The pandemic is still disrupting young people’s careers 
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal 
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
A sugar replacement called erythritol found in Splenda and Equal has been linked by a study to blood clotting, stroke, heart attack, and death.
Erythritolused is used to add bulk or sweeten stevia, monkfruit and keto reduced-sugar products.
Lead study author Dr. Stanley Hazen, director of the Center for Cardiovascular Diagnostics and Prevention at the Cleveland Clinic Lerner Research Institute, warned that “the degree of risk was not modest.”
The study, released on Monday in the journal Nature Medicine, found that people with pre-existing risk factors for heart disease, such as diabetes, were twice as likely to have a heart attack or stroke if they had the highest amounts of erythritol in their blood.
According to Hazen, there was an approximately two-fold increased risk for heart attack and stroke for those whose blood level of erythritol was in the top 25 percent as opposed to the lowest 25 percent. It is comparable to the most serious cardiac risk factors, such as diabetes.
Additional lab and animal research presented in the paper revealed that erythritol appeared to be causing blood platelets to clot more readily. Clots can break off and travel to the heart, triggering a heart attack, or to the brain, triggering a stroke.
Dr. Andrew Freeman, director of cardiovascular prevention and wellness at National Jewish Health, a hospital in Denver, said there appears to be a clotting risk from using erythritol, and that it might make sense to limit erythritol in your diet for now.”
Freeman was not involved in the research.
In response to the study, Robert Rankin, executive director of the Calorie Control Council, an industry association, said that “the results of this study are contrary to decades of scientific research showing reduced-calorie sweeteners like erythritol are safe, as evidenced by global regulatory permissions for their use in foods and beverages.”
Rankin added that the results “should not be extrapolated to the general population, as the participants in the intervention were already at increased risk for cardiovascular events.”
